Clinical Trials on Retinitis Pigmentosa in India

Total 11 results

Nanoscope Therapeutics Inc.

Completed

Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravitreal vMCO-I in Patients With Advanced Retinitis Pigmentosa

Retinal Degeneration | Retinal Diseases | Retinitis Pigmentosa

India
Chaitanya Hospital, Pune

Unknown

Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa

Retinitis Pigmentosa

India
Nanoscope Therapeutics Inc.

Enrolling by invitation

A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection (EXTEND)

Retinal Degeneration | Retinitis Pigmentosa | Retinal Disease

India
Aurolab

Completed

The Role of Capsular Tension Ring (CTR) in Anterior Capsular Contraction (ACO)

Retinitis Pigmentosa | Cataract

India
National Eye Institute (NEI)

Completed

Molecular Genetics of Retinal Degenerations

Retinal Degeneration | Retinitis Pigmentosa

United States, India, Pakistan, China
Humanis Saglık Anonim Sirketi

Completed

Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray

Perennial Allergic Rhinitis | Seasonal Allergic Rhinitis

India
Mahesh Bhattacharyya Homoeopathic Medical College...

Completed

Efficacy Study of Homeopathic Medicines in Treatment of Allergic Rhinitis and/or Induced Bronchial Asthma (SBRCTHILARBA)

Rhinitis; Allergic, With Asthma

India
Allergan

Completed

Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis

Rhinitis, Allergic, Seasonal | Conjunctivitis, Allergic

India
Karnataka Institute of Medical Sciences
Ministry of Science and Technology, India; Applied Genetics; Lab Discoveries...

Unknown

The Factors Associated With the Formation of Nasal polyp-a Case Control and Descriptive Study (ACAAGSONP)

Smoking | Allergic Rhinitis | Rhinosinusitis | Deviated Nasal Septum | Nasal Polyp | ASA Intolerant Asthma

India
GlaxoSmithKline

Completed

Bioequivalence of GW483100 10 Milligram (mg) Tablets in Healthy Subjects Under Fasting Conditions

Respiratory Disorders | Asthma and Rhinitis

India
Enovate Biolife Pvt Ltd

Unknown

A Randomized Double Dummy Double Blind Dose Determining Place-bo Controlled Study to Evaluate Efficacy of Investigational Product E-RH-06 at 2 Dose Levels for the Metabolic Management of Chronic or Recurrent, Non-infective Nasal Congestion With-or-without Rhinorrhea. (EB-RH-02-11)

Chronic Rhinitis

India

3

Subscribe